Ralimetinib Uses, Dosage, Side Effects and more
Ralimetinib has been used in trials studying the treatment of Postmenopausal, Advanced Cancer, Adult Glioblastoma, Fallopian Tube Cancer, and Metastatic Breast Cancer, among others.
| Trade Name | Ralimetinib |
| Generic | Ralimetinib |
| Ralimetinib Other Names | Ralimetinib |
| Type | |
| Formula | C24H29FN6 |
| Weight | Average: 420.536 Monoisotopic: 420.243773121 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
